Related by context. All words. (Click for frequent words.) 71 CHDI 68 ALN HTT 67 PsychoGenics 65 Aestus Therapeutics 65 Quark Pharmaceuticals 65 Ercole Biotech 65 Fovea Pharmaceuticals 65 & LSE GLPG 65 Argenta Discovery 65 Syntonix Pharmaceuticals 65 Provid Pharmaceuticals 64 Vaccinex 64 Galenea 64 PDE# inhibitors 64 OncoTherapy Science 64 Theraputics 64 Quark Biotech 64 Agios Pharmaceuticals 63 OncoMed Pharmaceuticals 63 Ceregene 63 Nasdaq LEXG 63 Melior Discovery 63 Phenomix Corporation 63 Portola Pharmaceuticals 63 Cenomed 63 Aileron Therapeutics 63 Knopp Neurosciences 63 glucokinase activator 63 Alnara Pharmaceuticals 63 Kosan dependence 63 Enanta Pharmaceuticals 63 Merrimack Pharmaceuticals 63 novel anti infective 63 FoldRx Pharmaceuticals Inc. 63 Akebia Therapeutics 63 Initiates Enrollment 62 commercialize Dimebon 62 FivePrime Therapeutics 62 TRACON Pharmaceuticals 62 Aerie Pharmaceuticals 62 EnVivo Pharmaceuticals 62 Seaside Therapeutics 62 OTCBB NRGX 62 OGeS 62 Pfizer Ophthalmics 62 JCR Pharmaceuticals 62 Hybridon 62 Vitae Pharmaceuticals 62 LEAD Therapeutics 62 recombinant biopharmaceutical 62 Inspiration Biopharmaceuticals 62 BioFocus DPI Galapagos 62 AnGes MG Inc. 62 RxKinetix 62 NYSE Amex PBTH 62 Viamet Pharmaceuticals 62 Neoprobe subsidiary Cira 62 Predix Pharmaceuticals 62 Cardioxyl Pharmaceuticals 62 Raven Biotechnologies 62 LentiVector technology 62 Teikoku Pharma USA 62 KAI Pharmaceuticals 62 Licenses Novel 61 Pervasis 61 SYN X 61 Therion Biologics 61 Ception Therapeutics 61 subsidiary Cira Biosciences 61 IR BioSciences Holdings 61 commercialize deforolimus 61 Epiphany Biosciences 61 Oxis International 61 Therapeutic Competitors companiesandmarkets.com adEgemonye 61 JAK2 inhibitor 61 Nasdaq IDIX 61 Potelligent Technology 61 Lexicon Genetics Incorporated 61 Immunotherapeutic 61 KAI Pharmaceuticals Inc. 61 Tikvah Therapeutics 61 Paradigm Genetics 61 Oxford Genome Sciences 61 Adenosine Therapeutics 61 OTCBB PYTO 61 NYSE Amex PTN 61 Sigma Tau Pharmaceuticals 61 Cara Therapeutics 61 FORMA Therapeutics 61 Accentia Biopharmaceuticals 61 Avila Therapeutics 61 Initiates Clinical Trial 61 KuDOS 61 ProMune 61 Reata Pharmaceuticals 61 NeuroSolutions 61 CFFT 61 Creabilis Therapeutics 61 Tibotec BVBA 61 Peptimmune 61 Ophthotech 61 RECOTHROM ® 61 Nasdaq HALO 61 Helicon Therapeutics 61 Xenon Pharmaceuticals 61 Initiates Phase II 61 Memgen 61 Exploit collaboration 61 PharmaNova 61 ZFP Therapeutics 61 Cellgate Inc. 61 Intellikine 61 tiapamil 61 NASDAQ CGEN announced 61 Genaera Corporation 60 Nasdaq VRTX 60 Shanghai Medicilon 60 FoldRx 60 Anaphore 60 Nasdaq ONXX 60 Bayhill Therapeutics 60 Napo Pharmaceuticals 60 Diatos SA 60 personalized cellular immunotherapy 60 Sirion Therapeutics 60 Nasdaq RXII 60 Locked Nucleic Acid 60 Acuity Pharmaceuticals 60 Galapagos NV Euronext 60 Archemix Corp. 60 Reports Preclinical Data 60 Expression Genetics 60 NASDAQ ISIS 60 PF # [002] 60 molecular chaperone regulation 60 Xytis 60 Lung Rx 60 Cambria Biosciences 60 OTCBB PYTO FWB ET6 60 Neurimmune 60 Biomarker Study 60 Mpex Pharmaceuticals 60 Marillion Pharmaceuticals 60 commercialize dimebon latrepirdine 60 Chroma Therapeutics 60 CureDM 60 FOLOTYN ® 60 Inc. AMEX YMI 60 Nasdaq IMGN 60 Neuroptix 60 Optivia Biotechnology 60 rxRNA 60 Awarded Qualifying Therapeutic 60 Nasdaq HALO biopharmaceutical 60 romazarit 60 Nasdaq DVAX 60 MolecularMD 60 Virdante 60 TolerRx 60 Inc. OTCBB SYBD 60 ChondroGene 60 Scynexis 60 Progenics Pharmaceuticals 60 NASDAQ CORT 60 candidate CRLX# 60 AmpliMed 60 immuno inflammatory diseases 60 Freedom Meditech 60 Nephros Therapeutics 60 Receives Milestone Payment 60 Versartis 60 Cellzome 60 Helinx technology 60 Sunshine Biopharma 60 AkaRx 60 Graffinity Pharmaceuticals 60 Adamis Pharmaceuticals 60 Idera Pharmaceuticals 60 TargeGen 60 Synosia Therapeutics 60 Chronogen 60 Fresenius Biotech 60 Ceflatonin R 60 Nasdaq ALNY 60 Tolerx 60 therapeutic monoclonal antibody 60 NYSE Amex AEN 60 P#X# antagonist 60 Apitope 60 ophthalmic therapeutics 60 CRO specializing 60 Intarcia 60 NasdaqGM NTEC today 60 Taiho Pharmaceutical 60 Begins Dosing 60 delivery polymer matrix 60 Enzo Therapeutics 60 Athenagen 59 Gemin X Biotechnologies 59 Nuon Therapeutics 59 Therapeutic Competitors Companies 59 Numoda 59 Ore Pharmaceuticals 59 Nasdaq IDRA today 59 PRNewswire FirstCall YM BioSciences 59 CeNeRx BioPharma 59 Pathway Diagnostics 59 InterfeRx 59 CCR9 antagonist 59 NASDAQ DRRX 59 mGluR2 positive 59 BrainCells 59 Trubion Pharma 59 StromaCel Inc. 59 Nasdaq IDRA 59 molecular imaging radiopharmaceutical 59 NeoGenesis 59 Receptos 59 Astex Therapeutics 59 NovaBay Aganocide compounds 59 Quark Pharmaceuticals Inc. 59 novel therapeutic antibodies 59 Prism Pharmaceuticals 59 novel antibody therapeutics 59 IG HCR ;) CO 59 OTCQX RHHBY 59 nicotinic alpha 7 59 ZaBeCor 59 SCIB1 59 NASDAQ FLML 59 Organon Pharmaceuticals 59 Cempra Pharmaceuticals 59 Inc. NASDAQ CLDA 59 Nasdaq CLDX 59 purinergic receptors P#X# 59 KineMed 59 HaptoGuard 59 Diasome Pharmaceuticals 59 developer Antisoma plc 59 Psynova 59 Lipocine 59 Amira Pharmaceuticals 59 AMEX DDD 59 Nasdaq ENZN 59 Viacell 59 GRN# 59 Molecular Profiling 59 Dynogen 59 Nycomed GmbH 59 Nasdaq FURX 59 Verus Pharmaceuticals 59 Syntonix 59 UCB Pharma SA 59 Initiates Clinical 59 Knopp Biosciences 59 Nasdaq CGEN 59 Aveo Pharmaceuticals 59 Senexis 59 Tigris Pharmaceuticals 59 Axxam 59 ASX PGL 59 EyeCyte 59 Aegera 59 Nasdaq IDIX biopharmaceutical 59 PRNewswire FirstCall Neurogen 59 MedGenesis 59 Gendux AB 59 Excelimmune 59 Rinat Neuroscience 59 Devax 59 Nasdaq OMER 59 Coronado Biosciences 59 TetraLogic Pharmaceuticals 59 Catalyst Biosciences 59 Validus Pharmaceuticals 59 Nasdaq NPSP 59 Xcytrin R 59 OTCBB IMNR 59 Wellstat 59 Gemin X 59 Epitomics 59 NASDAQ PCYC 59 Salmedix 59 Presidio Pharmaceuticals 59 Celltech Pharmaceuticals 59 Ergomed 59 Biotherapeutic 59 Sapphire Therapeutics 59 Ikaria Holdings Inc. 59 Nasdaq ENMD 59 ProMetic BioSciences 59 Biovista 59 Prodarsan R 59 PriCara ® 59 Clovis Oncology 59 cathepsin K inhibitor 59 Gentamicin Surgical Implant 59 Nexeon MedSystems 59 Inc. OTCBB CYKN 59 PGxHealth division 59 Endotis 59 BioTherapeutics 59 Clinsys Clinical Research 59 CellExSys 58 Locus Pharmaceuticals 58 Angiochem 58 Nastech Pharmaceutical Company 58 Genotyping Test 58 Stemgent 58 Biomodels 58 Cutanea Life Sciences 58 LymphoStat B TM 58 Merck Serono division 58 VisEn Medical 58 oncolytic virus therapies 58 Akesis Pharmaceuticals 58 AMEX ISV 58 Nereus Pharmaceuticals 58 UltiMAb 58 AviaraDx 58 aerosolized AAT 58 ISIS Pharmaceuticals 58 Ascenta Therapeutics 58 TransTech Pharma 58 QuatRx Pharmaceuticals 58 commercialize OncoGenex lead 58 Trubion Pharmaceuticals TRBN 58 Pancreate 58 OncoGenex Technologies 58 MPH AMEX 58 Cytokine PharmaSciences 58 Receives CE Marking 58 Inc. OTCBB ALRX 58 Nasdaq ISIS 58 iCardiac Technologies 58 PDE7 58 Phase 2a clinical trials 58 SinuNase ™ 58 novel peptides 58 GlycArt 58 novel antiviral therapeutics 58 Lycera 58 BioNumerik 58 AB OMXS BINV 58 NASDAQ ARRY 58 EpiTherapeutics 58 Regado Biosciences 58 Quark Biotech Inc. 58 Fujisawa Healthcare Inc. 58 GenWay Biotech 58 Adherex Technologies 58 Regulus Therapeutics 58 Neotropix 58 commercialize pimavanserin 58 Tranzyme Pharma 58 OrthoMEMS 58 acetonide FA 58 Nasdaq ACHN 58 Vernalis plc 58 PRNewswire FirstCall Isis Pharmaceuticals 58 Omeros Corporation 58 Pervasis Therapeutics Inc. 58 NASDAQ LGND 58 Ambrx 58 Addrenex Pharmaceuticals 58 Sutro Biopharma 58 Chromos Molecular Systems 58 Marinus Pharmaceuticals 58 visit http:/www.mannkindcorp.com 58 Ibis Biosciences 58 Sage Bionetworks 58 Initiates Phase III 58 BioAxone 58 NASDAQ INFI 58 NASDAQ EPIX 58 NYSE Amex OPK 58 AMEX KAL 58 apricitabine ATC 58 Durata Therapeutics 58 EHT AGN 58 Triapine 58 Alligator Bioscience AB 58 Aganocide ® 58 Phenomix 58 Nventa Biopharmaceuticals 58 Cellerant 58 Corixa Corporation 58 Addrenex 58 VentiRx Pharmaceuticals 58 Nanobac Life Sciences 58 NYSE BAX 58 acquire Molecular Devices 58 Metabasis Therapeutics Inc. 58 MEDAREX 58 Albugon 58 Cerenis Therapeutics 58 Jubilant Biosys 58 DPX Survivac 58 LSE ASM 58 NASDAQ PPDI 58 Epoch Biosciences 58 Galapagos NV Euronext GLPG 58 NASDAQ ALNY 58 Euronext Amsterdam GLPGA 58 targeted anticancer biopharmaceuticals 58 adrenergic regulation 58 Urocortin 2 58 Biotica 58 Bioral Amphotericin B 58 Naurex 58 NASDAQ PGNX 58 neurology immunology 58 SomaLogic 58 MacroMed 58 Singulex 58 QuantRx Biomedical Corporation 58 Saladax Biomedical 58 subsidiary Embryome Sciences 58 TSXV BIO 58 Bellus Health 58 Psivida 58 Kaketsuken 58 Inc. NASDAQ GLGC 58 Supernus Pharmaceuticals 58 Galapagos NV 58 Alnylam Nasdaq ALNY 58 deCODE chemistry 58 commercialize elagolix 58 Jaiva Technologies 58 BiolineRX 58 Epizyme 58 Expression Pathology 58 HuMax TAC 58 STEDESA 58 Ablaris Therapeutics 58 Taligen Therapeutics 58 subsidiaries visit http:/www.apricusbio.com 58 Piramed 58 Afferent 58 Personalized Immunotherapy 58 novel peptide 58 CVAF 58 ALTROPANE R 58 NTII 58 BioGeneriX 58 Cintredekin Besudotox 58 monoclonal antibody therapeutics 58 Potentia Pharmaceuticals 58 aldehyde dehydrogenase ALDH2 deficiency 58 POTELLIGENT R Technology 58 Tracon Pharmaceuticals 58 CRMD pharmaceutical 58 Prime BioResearch 58 Ocular Therapeutix 58 Inotek Pharmaceuticals Corporation 58 Sankyo Pharma 58 Plureon 58 Meritage Pharma 58 Stem Cell Innovations 58 Nasdaq RDEA 58 nephropathic cystinosis 58 Nasdaq CBST 58 superior bioprocessing 58 OTCBB HXBM developer 58 Relypsa 58 Oncovir 58 Celera CRA 58 Sylvie Gregoire President 58 Emphasys Medical 58 PAION AG ISIN 58 Roche SWX ROG 58 Selective Electrochemical Tumor Ablation 57 Biotherapeutics 57 Friedreich Ataxia FRDA 57 OTCBB DORB DOR 57 Molecular Templates 57 RenaMed Biologics 57 Targeted Chemotherapy 57 NASDAQ CLSN 57 Quotient Bioresearch 57 Lixivaptan 57 Paramount BioSciences 57 Aegis Therapeutics 57 OTCBB QTXB 57 UCB Pharma 57 OTCBB MCET 57 CoMentis 57 SensiGen 57 ALN RSV program 57 Nasdaq OMER biopharmaceutical 57 Volcano Therapeutics 57 Insegia 57 International LAB Pharma 57 BioSeek 57 Nasdaq PANC 57 Amphora Discovery 57 Merck OSI Pharmaceuticals 57 InnerCool Therapies 57 Inc. Nasdaq INFI 57 Amorcyte 57 Cellective Therapeutics 57 commercialize microRNA therapeutics 57 Neogenix 57 Atreus Pharmaceuticals 57 Optherion 57 Zelos Therapeutics 57 Neurome 57 Applied NeuroSolutions 57 Troxatyl 57 lixivaptan 57 NASDAQ TRBN 57 AMEX RGN 57 NASDAQ DIGE 57 BXT # 57 SIX RO ROG 57 Kosan epothilone program 57 NASDAQ OMER 57 tin ib targets 57 Nasdaq PGNX today 57 DirectSelect TM 57 Inc. Nasdaq ATHX 57 Sunovion 57 KaloBios 57 OTCBB CTIX 57 GVAX ® 57 ViroChem Pharma Inc. 57 Drew Fromkin President 57 Saegis Pharmaceuticals 57 Nasdaq DYAX 57 AQUA ® 57 Molecular Biotechnology CMB 57 Fc fusion protein 57 Idun Pharmaceuticals 57 Affinitak 57 Antitope 57 anticancer therapeutics 57 Acadia Pharmaceuticals 57 Traversa Therapeutics 57 AKIP 57 TTR amyloidosis 57 ImmunoGen TAP technology 57 Consortium MMRC 57 Chemokine Therapeutics 57 immatics 57 Amplimmune 57 Oxxon 57 Sristi Biosciences 57 pharmacological chaperone 57 OTCBB CHKT 57 Lexicon Genetics 57 NV Organon 57 Perlegen Sciences 57 MKC# MKC# PP 57 NASDAQ OGXI 57 Etubics 57 Stapled Peptide 57 Velcura Therapeutics 57 Nanotherapeutics 57 VentiRx 57 MicroDose 57 synthetic retinoid 57 Amex KAL 57 TRANSDUR ™ 57 Ampakine compounds 57 Tetraphase Pharmaceuticals 57 Tarvacin TM 57 allosteric modulation 57 Ambit Biosciences 57 Nasdaq INHX 57 Nasdaq VNDA 57 VaxImmune 57 Enters Into Collaboration 57 Adeona Pharmaceuticals Inc. 57 Scripps Genomic Medicine 57 botanical therapeutics 57 NeuroScience 57 Polyphor 57 Inotek 57 BioZone Laboratories 57 CombinatoRx Incorporated 57 Entelos 57 relapsed leukemia 57 immunotherapeutics 57 Aphton Corporation 57 Maxim Pharmaceuticals 57 OTCBB HNAB 57 Promedior 57 FluoroPharma 57 Amorfix Life Sciences 57 commercialize SGN 57 Taglich Brothers Initiates Coverage 57 PharmaDirections 57 Medicilon 57 Announces Poster Presentations 57 Amunix 57 NASDAQ IDEV 57 Inc. OTCBB IRBS 57 CytoPharm 57 Surfaxin LS 57 GSK Rare Diseases 57 Pharmacopeia Drug 57 Aerovance 57 Juvaris BioTherapeutics 57 MorphoSys proprietary 57 Iconix Pharmaceuticals 57 novel RNAi therapeutics 57 ADR IPSEY 57 Ikonisys 57 commercialize Aganocides 57 Celator 57 Lupuzor 57 Submits Biologics License Application 57 WeissComm Partners +#-#-#-# 57 kidney urologic 57 treat gastrointestinal disorders 57 including eniluracil ADH 57 Glaxo Wellcome plc 57 ACTCellerate 57 Paris IPN Euronext 57 Oncobionic 57 Cogane 57 Janssen Alzheimer Immunotherapy 57 IMRX 57 Genaissance Pharmaceuticals 57 Trubion Pharmaceuticals 57 Paradigm Therapeutics 57 Protalex Inc. 57 Scancell 57 Roche Trimeris 57 Accium BioSciences 57 CML HealthCare 57 Immtech Pharmaceuticals Inc. 57 DermTech International 57 Unit Dose Budesonide 57 Fabre Kramer 57 BN ImmunoTherapeutics 57 Cellgate 57 PRNewswire FirstCall Monogram Biosciences 57 Nasdaq PARD 57 psoriasis rheumatoid arthritis 57 Enhanze 57 NASDAQ ENMD 57 Mithridion 57 candidate custirsen 57 Tykerb lapatinib 57 Phylogica 57 RECOTHROM R 57 Aegera Therapeutics 57 ASONEP TM 57 Nasdaq XTLB 57 Orqis Medical 57 Nasdaq MNKD 57 Akela Pharma Inc. 57 Therapeutics CFFT 57 gastro intestinal inflammation 57 InterfeRx TM 57 YM BioSciences YM BioSciences 57 Excaliard 57 liposomal ciprofloxacin 57 Brussels THR 57 Perlecan Pharma 57 OTCBB IOPM 56 Nektar PEGylation technology 56 ALung Technologies 56 proprietary capillary aerosolization 56 DiaKine Therapeutics Inc. 56 FASgen 56 Migenix 56 Prometheus Laboratories 56 Resolvyx Pharmaceuticals 56 CureTech 56 Veronate R 56 AVAX Technologies Inc. 56 ospemifene 56 Trophos 56 Bone Biologics 56 Harry Palmin President 56 OSI Eyetech 56 AGTC 56 Athena Diagnostics 56 Uvidem 56 Zenvia ™ 56 Uli Hacksell Ph.D. 56 NYSE Amex BTX 56 ALS TDF 56 Cytori Therapeutics Inc. 56 Ono Pharmaceutical 56 TELINTRA R 56 Inc. NASDAQ IDMI 56 miRagen 56 InvaGen 56 Axial Biotech 56 Galderma SA 56 PrevOnco 56 dutogliptin 56 Frankfurt XMP 56 NeuroMedix 56 EndoBiologics 56 Factor VIIa 56 pralatrexate injection folate analogue 56 Panzem ® 56 Cerimon 56 CrystalGenomics 56 Biomarker Discovery Center 56 H3 Biomedicine 56 Ovation Pharmaceuticals Inc. 56 IND Investigational New 56 investigational therapies 56 Nasdaq AVNR 56 Submits Response 56 DiscoveRx 56 CytomX Therapeutics 56 Ipsen Euronext IPN 56 PolyTherics 56 LifeSpan BioSciences 56 EnVivo 56 Cellectar 56 ChemDiv 56 OMP #R# 56 Nasdaq TGEN 56 Trellis Bioscience 56 Bioral 56 Albany Molecular AMRI 56 enGene 56 Adventrx Pharmaceuticals 56 SurroMed 56 HuLuc# 56 Inc. Nasdaq CRTX 56 AskBio 56 TSX VENTURE IMV 56 BTG plc 56 EMD Biosciences Inc. 56 PentaLyte R 56 BioWa 56 isoform selective 56 Memryte 56 Zygogen 56 Prometheus Laboratories Inc. 56 Nasdaq PCYC 56 PharmaPros 56 candidate epratuzumab 56 Somnus Therapeutics 56 TSX VENTURE COT 56 Avera Pharmaceuticals 56 Synthetic Genomics Vaccines 56 Syrrx 56 BrainCells Inc. 56 Glassia 56 Circ Pharma 56 targeted radiotherapeutic 56 Proventys 56 NormOxys 56 pharmacogenomic tests 56 DeveloGen 56 Celladon 56 antibacterial therapeutics 56 MacroPore 56 OMJPI 56 Rondaxe 56 Transition Therapeutics 56 ArQule Kinase Inhibitor Platform 56 HELSINN 56 REGiMMUNE 56 GlaxoSmithKline plc GSK 56 BioProcessors 56 NASH Huntington 56 neurogenic orthostatic hypotension 56 Inc. NASDAQ KNDL 56 OncoGenex Pharmaceuticals Inc. 56 VasoGenix Pharmaceuticals 56 predictive toxicology 56 NASDAQ SMMX 56 EP #R 56 QuatRx 56 GSK '# 56 Garnet BioTherapeutics 56 CDP# 56 Cenix BioScience 56 NASDAQ DYAX 56 PHX# 56 JAK inhibitor 56 Inc. NASDAQ PPDI 56 NASDAQ TGEN 56 candidates Azedra TM 56 Isis Pharma 56 ZFP Therapeutic 56 TSX CTI 56 Iomai Corporation 56 Inc. OTCBB CYGX 56 Pyro Pharmaceuticals 56 Nuron Biotech 56 INS# [001] 56 acyclovir Lauriad R 56 NEUGENE R 56 ALN PCS 56 GeneOhm Sciences 56 Commercialize Novel 56 Synergy Pharmaceuticals 56 Source MDx 56 Pfizer Regenerative Medicine 56 Cyclacel Pharmaceuticals 56 Celladon Corporation 56 OTCBB ADMP 56 Avalon Pharmaceuticals 56 Innovive Pharmaceuticals 56 Aegerion Pharmaceuticals Inc. 56 TSX SHQ 56 Nasdaq IVGN 56 Vybion 56 PhotoThera 56 Sunovion Pharmaceuticals Inc. 56 NASDAQ OSIR 56 Nasdaq ACAD 56 telomerase therapeutic 56 AVXL 56 EGRIFTA TM 56 Corautus Genetics 56 Proneuron 56 novel immunotherapeutic 56 Allon Therapeutics 56 Nasdaq MITI biopharmaceutical 56 YM AIM YMBA 56 Array BioPharma 56 NTDDS 56 HistoRx 56 Cell Signaling Technology 56 Naglazyme R 56 IL# PE#QQR 56 ABOUT INC. 56 NPS Pharma 56 Nasdaq ALXN 56 IGXT 56 ANAVEX 56 Virium 56 candidate deforolimus 56 OvaRex R 56 ASONEP 56 Ingenuity Systems 56 Biovail Laboratories International 56 OncoMed 56 Syndax 56 Inc. NASDAQ NOVC 56 ARIUS Research 56 Dynepo TM 56 MAXY VII 56 Nasdaq NRGN 56 Zenyaku Kogyo 56 please visit www.metabolon.com 56 IMPACS R 56 AION Diagnostics 56 OTCBB CHKT biotechnology 56 Tragara Pharmaceuticals Inc. 56 NASDAQ IDRA 56 Alder Biopharmaceuticals 56 SOLVAY PHARMACEUTICALS 56 siRNA therapeutics 56 Kyowa Hakko Kirin 56 OTCBB INSV 56 Epix Pharmaceuticals 56 Myocet 56 Genesis Biopharma Inc. 56 Edimer Pharmaceuticals 56 HemoGenix 56 Inc. Nasdaq ALNY 56 optical biosensors 56 F. Hoffmann LaRoche 56 Shigamabs R 56 Hedgehog antagonist 56 BLP# Liposome Vaccine 56 NKT Therapeutics 56 Ltd. OTCBB IMUC 56 Nasdaq SPPI 56 Kiadis 56 PRNewswire FirstCall Nastech Pharmaceutical 56 Merrion Pharmaceuticals 56 anti CD3 monoclonal 56 Gemin X Pharmaceuticals 56 KL4 Surfactant 56 London AiM GLPG 56 vaccines oncolytic virus 56 Initiates Phase 2b 56 Response Genetics 56 Primus Pharmaceuticals 56 Cardiokine 56 MCU cardiovascular 56 Genome Therapeutics 56 Aviptadil 56 Prednisporin 56 Phusion Laboratories 56 Kalypsys 56 diabetes irritable bowel 56 POSIDUR TM ELADUR TM 56 Sangamo ZFP technology 56 TaiGen 56 Inpharmatica 56 Alnylam Biotherapeutics 56 NASDAQ ABII 56 NASDAQ REGN 56 Yamanouchi Pharmaceutical Co. 56 Calistoga Pharmaceuticals 56 Nasdaq ACEL 56 CINTREDEKIN BESUDOTOX 56 VitiGam 56 IND enabling 56 mGluR2 NAM 56 Supernus 56 CeNeS Pharmaceuticals plc 56 therapeutic monoclonal antibodies 56 Seikagaku 56 HuCAL PLATINUM R 56 Transcept Pharmaceuticals 56 Oxxon Therapeutics 56 Nasdaq TRBN 56 ADMETRx 56 commercializing aptamer therapeutics 56 GTC NASDAQ GTCB 56 5 lipoxygenase activating 56 ChemGenex Pharmaceuticals 56 Celera Diagnostics joint venture 56 Nicholas Nicolaides 56 phase IIb trial 56 High Throughput Genomics 56 Trine Pharmaceuticals 56 Nasdaq LXRX biopharmaceutical 56 Conatus Pharmaceuticals 56 RNA interference RNAi therapeutics 56 OncoVex 56 Alnylam RNAi 56 NASDAQ EMIS 56 Phase IIb clinical trials 56 GlycoMimetics 56 Elan Pharma 56 Inc. OTCBB SPRX 56 Nitric Bio 56 Hyperion Therapeutics 56 Ceragenin ™ 56 MacroGenics 56 commercialize apixaban 56 Fraunhofer USA 56 Adnectin 56 ARRY # 56 biosimulation 56 mertansine 56 Research MJFF 56 Inc. OTCBB OXIS 56 Genocea Biosciences 56 INTERCEPT red 56 IAP inhibitor 56 OTCBB CVBT 56 GlaxoSmithKline MedImmune 56 ExonHit Therapeutics SA 56 ProSanos 56 HepeX B 56 Cascade LifeSciences 56 LUCASSIN 56 CYT# potent vascular disrupting 56 TSX VENTURE GAP 56 CRMD# 56 Xenogen Corporation 56 www.ucb group.com 56 ELADUR ™ 56 Anticalin 56 novel immunotherapies 56 NASDAQ ENZN 56 Avantra Biosciences 56 codevelop 56 introduced NEUGENE 56 Proteome Systems 56 Diosynth RTP 56 Cardiac Dimensions 56 PharmaBio Development 56 CIPH 56 TRANSDUR ® 56 Campath ® 56 Achillion Pharmaceuticals Inc. 56 NYSE Amex RGN 56 VIA Pharmaceuticals 56 JAK1 56 Bexion 56 Alder Biopharmaceuticals Inc. 56 ChemoCentryx 56 CoLucid 56 Malaria Venture MMV 56 DermTech 56 Nasdaq MBRX announced 56 proprietary PEGylation 56 Althea Technologies 56 miRNA therapeutics 56 Vysis 56 Synerx Pharma 56 Crucell PER.C6 56 Miikana Therapeutics 56 successfully commercialize Iluvien 56 Oxagen 56 Profectus Biosciences 56 Chemo Sero Therapeutic 56 Receive Milestone Payment 55 Cell Medica 55 NABTT